Answer
The most commonly reported side effects of Imlygic (talimogene laherparepvec) were fatigue (50.3%), chills (48.6%), fever (42.8%), nausea (35.6%), flu-like illness (30.5%) and injection-site pain (27.7%); 98% of these reported reactions were mild or moderate.
Sources for this answer
- ImlygicAmgen Ltd · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked